Fas and ceramide inhibition of the phosphatidylinositol-3-kinase (PI3K) cell survival pathway in human granulosa luteal cells (hGLC).

被引：0
|
作者：
Nakad, TI
Pru, JK
Hendry, IR
Davis, JS
Rueda, BR
机构：
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Boston, MA 02115 USA
[2] Vet Affairs Med Ctr, Wichita, KS USA
[3] Univ Kansas, Sch Med, Womens Res Inst, Wichita, KS 67214 USA
来源：
FERTILITY AND STERILITY | 2001年 / 76卷 / 03期
关键词：
D O I：
10.1016/S0015-0282(01)02625-5
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P297
引用
收藏
页码：S209 / S210
页数：2
相关论文
共 50 条
  • [1] Survival of porcine granulosa cells is mediated by a phosphatidylinositol-3-kinase (PI-3-kinase) signaling pathway.
    Westfall, SD
    Fong, HW
    Rueda, BR
    Davis, JS
    BIOLOGY OF REPRODUCTION, 1998, 58 : 113 - 113
  • [2] Role of phosphatidylinositol-3-kinase (PI3K) in cardioprotection.
    Steenbergen, C
    Tong, HY
    Murphy, E
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (06) : A10 - A10
  • [3] Managing toxicities of phosphatidylinositol-3-kinase (PI3K) inhibitors
    Hanlon, Ashley
    Brander, Danielle M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 346 - 356
  • [4] Diosgenin inhibits melanogenesis through the activation of phosphatidylinositol-3-kinase pathway (PI3K) signaling
    Lee, Jongsung
    Jung, Kwangseon
    Kim, Yeong Shik
    Park, Deokhoon
    LIFE SCIENCES, 2007, 81 (03) : 249 - 254
  • [5] Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology
    Curigliano, Giuseppe
    Shah, Rashmi R.
    DRUG SAFETY, 2019, 42 (02) : 247 - 262
  • [6] Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology
    Giuseppe Curigliano
    Rashmi R. Shah
    Drug Safety, 2019, 42 : 247 - 262
  • [7] Multitarget Inhibition of Histone Deacetylase (HDAC) and Phosphatidylinositol-3-kinase (PI3K): Current and Future Prospects
    Rodrigues, Daniel A.
    Pinheiro, Pedro S. M.
    Fraga, Carlos A. M.
    CHEMMEDCHEM, 2021, 16 (03) : 448 - 457
  • [8] Phosphatidylinositol 3-kinase (PI3K) pathway - A therapeutic target for human glioblastoma
    Koul, Dimpy
    Shen, Ruijun
    Edge, Jennifer
    Liu, T. J.
    Powis, Garth
    Lynn Kirkpatrick, D.
    Alfred Yung, W. K.
    NEURO-ONCOLOGY, 2006, 8 (04) : 414 - 414
  • [9] Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma
    Trautmann, Marcel
    Cyra, Magdalene
    Isfort, Ilka
    Jeiler, Birte
    Krueger, Arne
    Gruenewald, Inga
    Steinestel, Konrad
    Altvater, Bianca
    Rossig, Claudia
    Hafner, Susanne
    Simmet, Thomas
    Becker, Jessica
    Amana, Pierre
    Wardelmann, Eva
    Huss, Sebastian
    Hartmann, Wolfgang
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (04) : 834 - 844
  • [10] Hyperglycemia secondary to phosphatidylinositol-3 kinase (PI3K) inhibition
    Sriravindrarajah, Arunan
    Hurwitz, Joshua
    Lim, Elgene
    Greenfield, Jerry R.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2024, 2024 (04):
12345